Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by PAPPAGIANIS, D.
Right arrow Articles by LEVINE, H. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PAPPAGIANIS, D.
Right arrow Articles by LEVINE, H. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 102, No. 1: 30-41
Copyright © 1975 by The Johns Hopkins University School of Hygiene and Public Health

other

THE PRESENT STATUS OF VACCINATION AGAINST COCCIDIOIDOMYCOSIS IN MAN

DEMOSTHENES PAPPAGIANIS1, and H. B. LEVINE2

1Department of Medical Microbiology, School of Medicine, University of California Davis, CA 95616
2Naval Biomedical Research Laboratory, University of California Berkeley, CA

address for reprint requests

Pappagianis, D. (School of Medicine, U of California, Davis, CA 95616) and H. B. Levine. The present status of vaccination against coccidioidomycosis in man. Am J Epidemiol 102:30–41, 1975.—Vaccines of killed whole cells of Coccidioides immitis have been injected intramuscularly in 97 human subjects to determine the safety and tolerable dose of vaccine and certain immunologic responses. Seventyeight individuals received the whole killed spherule preparation; 18 received killed mycelial vaccine. The maximum tolerable dose of spherule vaccine was approximately 5 mg. Systemic effects were slight though in two prior coccidioidin reactors a moderate febrile illness and substantial antibody production followed vaccination with killed spherules. The vaccines irregularly induced antibody or delayed hypersensitivity to coccidioidin or spherule antigen. Greater antigenic mass perhaps as a soluble preparation may be needed for consistent immunologic stimulation though the spherule vaccine may be protective despite absence of detectable antibody or sensitivity to coccidioidin.

Coccidioides immitis; coccidioidomycosis vaccine; fungal vaccines


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
L. F. Shubitz, S. M. Dial, R. Perrill, R. Casement, and J. N. Galgiani
Vaccine-Induced Cellular Immune Responses Differ from Innate Responses in Susceptible and Resistant Strains of Mice Infected with Coccidioides posadasii
Infect. Immun., December 1, 2008; 76(12): 5553 - 5564.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
R. A. Cox and D. M. Magee
Coccidioidomycosis: Host Response and Vaccine Development
Clin. Microbiol. Rev., October 1, 2004; 17(4): 804 - 839.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. O. Abuodeh, L. F. Shubitz, E. Siegel, S. Snyder, T. Peng, K. I. Orsborn, E. Brummer, D. A. Stevens, and J. N. Galgiani
Resistance to Coccidioides immitis in Mice after Immunization with Recombinant Protein or a DNA Vaccine of a Proline-Rich Antigen
Infect. Immun., June 1, 1999; 67(6): 2935 - 2940.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
I. M. Cohen, J. N. Galgiani, D. Potter, and D. A. Ogden
Coccidioidomycosis in Renal Replacement Therapy
Arch Intern Med, March 1, 1982; 142(3): 489 - 494.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.